Medical School

  • University of Sherbrooke , 2013 , Sherbrooke, Quebec , Canada


  • CHU Sainte-Justine , 2014 , Montreal , Quebec, Canada


  • CHU Sainte-Justine , 2016 , Montreal, Quebec , Canada


  • Boston Children's Hospital , 2019 , Boston , MA


  • Boston Children's Hospital , 2020 , Boston , MA


  • American Board of Pediatrics, General Pediatrics


Publications powered by Harvard Catalyst Profiles

  1. An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Pediatr Infect Dis J. 2022 01 01; 41(1):e6-e9. View abstract
  2. Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults. Circulation. 2021 Dec 06. View abstract
  3. Deep Learning-Based Approach to Automatically Assess Coronary Distensibility Following Kawasaki Disease. Pediatr Cardiol. 2021 Dec 02. View abstract
  4. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021 12 01; 6(12):1446-1450. View abstract
  5. Author's Response. Pediatrics. 2021 11; 148(5). View abstract
  6. Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children. Pediatr Blood Cancer. 2021 12; 68(12):e29355. View abstract
  7. Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms. J Cardiovasc Comput Tomogr. 2022 Jan-Feb; 16(1):43-50. View abstract
  8. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives. Am Heart J. 2022 01; 243:43-53. View abstract
  9. Coronary artery aneurysms in children is not always Kawasaki disease: a case report on Takayasu arteritis. BMC Rheumatol. 2021 Aug 12; 5(1):27. View abstract
  10. Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study. Arch Dis Child. 2021 Jul 08. View abstract
  11. Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome. Can J Cardiol. 2021 10; 37(10):1619-1628. View abstract
  12. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis. CJC Open. 2021 Jul; 3(7):880-887. View abstract
  13. Rapid ascending aorta stiffening in bicuspid aortic valve on serial cardiovascular magnetic resonance evaluation: comparison with connective tissue disorders. J Cardiovasc Magn Reson. 2021 02 22; 23(1):11. View abstract
  14. Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome. Pediatrics. 2021 05; 147(5). View abstract
  15. The Electrocardiogram in Multisystem Inflammatory Syndrome in Children: Mind Your Ps and Qs. J Pediatr. 2021 07; 234:10-11. View abstract
  16. Cardiac hemodynamics in fetuses with transposition of the great arteries and intact ventricular septum from diagnosis to end of pregnancy: longitudinal follow-up. Ultrasound Obstet Gynecol. 2021 02; 57(2):273-281. View abstract
  17. Variation in the management of Kawasaki disease in Australia and New Zealand: A survey of paediatricians. J Paediatr Child Health. 2021 May; 57(5):646-652. View abstract
  18. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 2021 01 05; 143(1):78-88. View abstract
  19. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950. View abstract
  20. Risk Factors for Early Recurrence Following Ablation for Accessory Pathways: The Role of Consolidation Lesions. Circ Arrhythm Electrophysiol. 2020 11; 13(11):e008848. View abstract
  21. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child. 2021 03; 106(3):247-252. View abstract
  22. Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry. CJC Open. 2020 Nov; 2(6):632-640. View abstract
  23. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome. Pediatrics. 2020 11; 146(5). View abstract
  24. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021 Feb; 180(2):307-322. View abstract
  25. Value of provocative electrophysiology testing in the management of pediatric patients after congenital heart surgery. Pacing Clin Electrophysiol. 2020 09; 43(9):901-907. View abstract
  26. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP). Pediatr Cardiol. 2020 Jun; 41(5):947-954. View abstract
  27. Value of Troponin Testing for Detection of Heart Disease in Previously Healthy Children. J Am Heart Assoc. 2020 02 18; 9(4):e012897. View abstract
  28. Anti-thrombosis management of patients with Kawasaki disease: Results from an international survey. Int J Cardiol. 2020 05 15; 307:154-158. View abstract
  29. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease. J Pediatr. 2019 09; 212:87-92. View abstract
  30. Variation in the management of Kawasaki disease. Arch Dis Child. 2020 10; 105(10):1004-1006. View abstract
  31. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. Pediatrics. 2019 06; 143(6). View abstract
  32. Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection. PLoS One. 2018; 13(10):e0206001. View abstract
  33. A Decade of NT-proBNP in Acute Kawasaki Disease, from Physiological Response to Clinical Relevance. Children (Basel). 2018 Oct 12; 5(10). View abstract
  34. Difference Between Persistent Aneurysm, Regressed Aneurysm, and Coronary Dilation in Kawasaki Disease: An Optical Coherence Tomography Study. Can J Cardiol. 2018 09; 34(9):1120-1128. View abstract
  35. Myocarditis and Kawasaki disease. Int J Rheum Dis. 2018 Jan; 21(1):45-49. View abstract
  36. Dynamic QT Interval Changes from Supine to Standing in Healthy Children. Can J Cardiol. 2018 01; 34(1):66-72. View abstract
  37. Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease. Pediatrics. 2017 Jun; 139(6). View abstract
  38. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease. Pediatr Int. 2017 Mar; 59(3):265-270. View abstract
  39. Importance of anatomical dominance in the evaluation of coronary dilatation in Kawasaki disease. Cardiol Young. 2017 Jul; 27(5):877-883. View abstract
  40. Fatal Kawasaki disease with incomplete criteria: Correlation between optical coherence tomography and pathology. Pediatr Int. 2015 Dec; 57(6):1174-8. View abstract
  41. Coronary Wall Structural Changes in Patients With Kawasaki Disease: New Insights From Optical Coherence Tomography (OCT). J Am Heart Assoc. 2015 May 19; 4(5). View abstract
  42. Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease. Clin Endocrinol (Oxf). 2014 Feb; 80(2):296-300. View abstract